BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 6328258)

  • 1. Response of puppies to canine-origin parvovirus vaccines.
    Carmichael LE; Pollock RV; Joubert JC
    Mod Vet Pract; 1984 Feb; 65(2):99-102. PubMed ID: 6328258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of selected canine vaccines for their ability to induce protective immunity against canine parvovirus infection.
    Larson LJ; Schultz RD
    Am J Vet Res; 1997 Apr; 58(4):360-3. PubMed ID: 9099379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Canine parvovirus type 2 vaccine protects against virulent challenge with type 2c virus.
    Spibey N; Greenwood NM; Sutton D; Chalmers WS; Tarpey I
    Vet Microbiol; 2008 Apr; 128(1-2):48-55. PubMed ID: 18006253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response of pups with maternal derived antibody to modified-live canine parvovirus vaccine.
    Buonavoglia C; Tollis M; Buonavoglia D; Puccini A
    Comp Immunol Microbiol Infect Dis; 1992 Oct; 15(4):281-3. PubMed ID: 1330425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccination with canine parvovirus type 2 (CPV-2) protects against challenge with virulent CPV-2b and CPV-2c.
    Siedek EM; Schmidt H; Sture GH; Raue R
    Berl Munch Tierarztl Wochenschr; 2011; 124(1-2):58-64. PubMed ID: 21306055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Canine parvovirus immunoprophylaxis: a review.
    Moore DJ
    J S Afr Vet Assoc; 1983 Dec; 54(4):259-64. PubMed ID: 6321731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response of pups to modified-live canine parvovirus component in a combination vaccine.
    O'Brien SE; Roth JA; Hill BL
    J Am Vet Med Assoc; 1986 Apr; 188(7):699-701. PubMed ID: 3700224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of two canine parvovirus vaccines for inducing seroconversion in Rottweiler and Doberman pinscher pups with various levels of maternally derived antibodies.
    Coyne MJ
    Vet Ther; 2000; 1(1):35-42. PubMed ID: 19757563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Field evaluation of a canine parvovirus vaccination program, using feline origin modified live virus vaccine.
    Gordon JC; Rogers WA
    J Am Vet Med Assoc; 1982 Jun; 180(12):1429-31. PubMed ID: 6284689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody levels and protection to canine parvovirus type 2.
    Elia G; Cavalli A; Cirone F; Lorusso E; Camero M; Buonavoglia D; Tempesta M
    J Vet Med B Infect Dis Vet Public Health; 2005; 52(7-8):320-2. PubMed ID: 16316392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternally derived immunity to canine parvovirus infection: transfer, decline, and interference with vaccination.
    Pollock RV; Carmichael LE
    J Am Vet Med Assoc; 1982 Jan; 180(1):37-42. PubMed ID: 7056660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three-year rabies duration of immunity in dogs following vaccination with a core combination vaccine against canine distemper virus, canine adenovirus type-1, canine parvovirus, and rabies virus.
    Lakshmanan N; Gore TC; Duncan KL; Coyne MJ; Lum MA; Sterner FJ
    Vet Ther; 2006; 7(3):223-31. PubMed ID: 17039445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serologic response of pups to the low-passage, modified-live canine parvovirus-2 component in a combination vaccine.
    O'Brien SE
    J Am Vet Med Assoc; 1994 Apr; 204(8):1207-9. PubMed ID: 8014088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunization of pups with maternally derived antibodies to canine parvovirus (CPV) using a modified-live variant (CPV-2b).
    Pratelli A; Cavalli A; Normanno G; De Palma MG; Pastorelli G; Martella V; Buonavoglia C
    J Vet Med B Infect Dis Vet Public Health; 2000 May; 47(4):273-6. PubMed ID: 10861195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early protection of puppies against canine parvovirus: a comparison of two vaccines.
    McCaw DL; Tate D; Dubovi EJ; Johnson JC
    J Am Anim Hosp Assoc; 1997; 33(3):244-50. PubMed ID: 9138235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dog response to inactivated canine parvovirus and feline panleukopenia virus vaccines.
    Pollock RV; Carmichael LE
    Cornell Vet; 1982 Jan; 72(1):16-35. PubMed ID: 6279359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the efficacy and duration of immunity of a canine combination vaccine against virulent parvovirus, infectious canine hepatitis virus, and distemper virus experimental challenges.
    Abdelmagid OY; Larson L; Payne L; Tubbs A; Wasmoen T; Schultz R
    Vet Ther; 2004; 5(3):173-86. PubMed ID: 15578450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A modified live canine parvovirus vaccine. II. Immune response.
    Carmichael LE; Joubert JC; Pollock RV
    Cornell Vet; 1983 Jan; 73(1):13-29. PubMed ID: 6337780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Case report: effect of maternal antibodies on the vaccination against canine parvovirus].
    Schunck B; Truyen U
    Tierarztl Prax; 1995 Apr; 23(2):185-6. PubMed ID: 7624862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effectiveness and safety of an immunization against parvovirus and rabies in anesthetized puppies].
    Mayr B; Hönig A; Gutbrod F; Wiedemann C
    Tierarztl Prax; 1990 Apr; 18(2):165-9. PubMed ID: 2161572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.